Drug industry deal-making starts year with a bang
Sanofi to acquire hemophilia-focused Bioverativ; Celgene to get CAR T-cell immunotherapy maker Juno
Source: Chemical and Engineering News - Category: Chemistry Authors: Ryan Cross Source Type: research